SEC Investigates Galena Biopharma

Galena Biopharma Inc. (Nasdaq: GALE) disclosed that the Securities and Exchange Commission was investigating the company for engaging in a stock promotion campaign. The stock price fell 35 cents to $2.87.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.